A detailed history of Nuveen, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Nuveen, LLC holds 133,293 shares of HAE stock, worth $9.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,293
Previous 138,587 3.82%
Holding current value
$9.8 Million
Previous $10.3 Million 37.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$47.67 - $78.17 $252,364 - $413,831
-5,294 Reduced 3.82%
133,293 $6.5 Million
Q2 2025

Aug 12, 2025

SELL
$56.04 - $74.77 $1.35 Million - $1.8 Million
-24,119 Reduced 14.82%
138,587 $10.3 Million
Q1 2025

May 12, 2025

BUY
$59.34 - $80.05 $9.65 Million - $13 Million
162,706 New
162,706 $10.3 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.